Alveo Technologies and Government of Barbados Collaborate to Co-Develop Advanced Molecular Disease Diagnostics Across Multiple End Markets
Published on: Thursday 05 January 2023
ALAMEDA, Calif., January 05, 2023--Alveo Technologies, Inc., (Alveo) a leader in molecular sensing and diagnostics with its proprietary be.well™ technology platform, in its quest to drive earlier detection of pathogens at the point of need, today announced it has signed a Memorandum of Understanding (MOU) with the Barbados Investment and Development Corporation (Export Barbados (BIDC)) to co-develop on its novel molecular sensing platform, while contributing to the growth of the life sciences in
RELATED NEWS
